Drug
Vabicaserin hydrochloride clinical trials
Also written SCA-136.
A product of Vabicaserin; its studies count on that page too.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
- SCA-136
- 4
Studies by the year they started
6 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Vabicaserin
- One of Serotonin Receptor Agonists source
Studies
Open first, then newest update. How each study uses vabicaserin hydrochloride is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of SchizophreniaWithdrawnPhase 2Wyeth is now a wholly owned subsidiary of PfizerNCT00768612Written as SCA-136 50mg/day
- Safety, PK and PD Study in Healthy Male Japanese SubjectsCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00447941Written as SCA-136
- Study Evaluating SCA-136 in Subjects With Acute Exacerbations of SchizophreniaCompletedPhase 2Wyeth is now a wholly owned subsidiary of PfizerNCT00265551Written as SCA-136 (200 mg)
- Study Evaluating SCA-136 Tolerability With Dose Titration and FoodTerminatedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00420706Written as SCA-136
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male SubjectsCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00505973Written as SCA-136
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female SubjectsCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00458107Written as SCA-136
Codes
What other systems call vabicaserin hydrochloride · ClinicalTrials.gg INT014432
- UNII (FDA) 2759C7222CVABICASERIN HYDROCHLORIDEConfirmed FDA, Wikidata
- Wikidata Q27254166vabicaserin hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C142993Vabicaserin HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2759C7222C | VABICASERIN HYDROCHLORIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27254166 | vabicaserin hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C142993 | Vabicaserin Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.